أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

Greg Brew on Surging Energy and the 'Strategic Trap' of the War in Iran

This Is Iran's Strategy to win.

Markets Are Underpricing This Commodity Shock

Markets are underpricing the supply shock stemming from the interruption of oil flows through the Strait of Hormuz. Rates are …

Economists Pivot to See ECB Hikes While Diverging on First Move

Economists are shifting to align with the market view that European Central Bank interest-rate hikes are inevitable within months.

Rühl: US Almost Out of Options to Keep Oil Price Low

Attacks on oil and gas infrastructure in the Arabian Gulf have escalated in the past two days. After a rebuke …

European Gas Falls as US, Israel Seek to Ease Iran War Concerns

European natural gas fell after Israel and the US sought to ease concerns about further attacks on Persian Gulf energy …

Asia Turns to Coal as Iran War Rapidly Shrinks Supplies of Gas

War in the Middle East is forcing Asia to turn to coal to plug the gaping hole emerging in its …

VinFast Risks North Carolina Clawback of US EV Plant Incentives

Pressure is mounting on VinFast Auto Ltd. after two US officials reminded the Vietnamese EV maker of its obligations under …

Dangote Demand Soars As War Disrupts Africa Fuel Supply

African nations are scrambling to secure fuel from Nigeria's Dangote Refinery as war in the Middle East disrupts supply. The …

Unilever Confirms Talks on McCormick Offer for Food Business

Unilever Plc said it’s in discussions to sell its food business to McCormick & Co. in a major shift for …

Bitcoin’s price action looks dangerously similar to the pattern that sent it crashing to $60,000

The recent price action echoes the November–January pattern, showing weak conviction among the “buy the dip” crowd.

Where Billionaire Raamdeo Agrawal Is Finding Value in India

Indian equities have slumped as the ongoing war in Iran drives energy prices sharply higher. Billionaire investor Raamdeo Agrawal, Chairman …

Novartis to Buy Breast Cancer Drug for as Much as $3 Billion

Novartis AG agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3 billion to …